hdr isap 2019

Annual meeting 2023

This year, we were honoured to be joined by Professor Oana Ciofu as a Keynote Speaker to kick off the meeting with an insightful talk on the efforts to combat biofilm infections.


The meeting was followed by the traditional ISAP Young Investigator session, chaired by Dr. Vincent Aranzana-Climent (France), Dr. Iris Minichmayr (Austria) and Dr. Sue C. Nang (Australia). It was fascinating to hear about excellent research conducted by our talented ISAP Young Investigators.



Noémie Prébonnaud

Université de Poitiers, France

Predicting antibacterial efficacy of linezolid on Staphylococcus aureus in cerebral infections using in vitro hollow fiber model and pharmacokinetic-pharmacodynamic modeling

Aneeq Farooq

University of Hamburg, Germany

Pharmacokinetic/pharmacodynamic studies of meropenem combined with fosfomycin in a clinical K. pneumoniae isolate expressing KPC-2 carbapenemase and fosfomycin resistance

Mathilde Lacroix

Université de Poitiers, France

Transcriptomic data to support in vitro semi-mechanistic PK/PD modelling of polymyxin B against Acinetobacter baumannii

Chenyan Zhao

Uppsalla University, Sweden

Characterizing bacterial growth and killing kinetics of RG6006 using in vitro and in vivo time-kill studies and mechanism-based pharmacokinetic-pharmacodynamic (PKPD) modeling

Thomas D. Nguyen

University at Buffalo, USA

Developing a mechanistically informed population pharmacokinetic model of vancomycin in patients undergoing intermittent hemodialysis

Augustine Koh

Melbourne University, Australia

Investigating Leu10Teixobactin combinations with glycopeptides against multidrug-resistant Gram-positive pathogens

Eva Wehrhahn

Uppsalla University, Sweden

Quantification of antibiotic-induced changes in bacterial counts and morphology using timelapse microscopy, image analysis, machine learning and pharmacokinetic-pharmacodynamic modelling

Malin Andersson

Freie Universität Berlin, Germany

Beyond the standard ratio: Quantitative exploration of the effect of piperacillin with varying tazobactam concentrations

Gert-Jan Wijnant

Université catholique de Louvain, Belgium

Population pharmacokinetics and dosing simulation of the β-lactam temocillin in liver-transplanted pediatric patients

Hélène Thirot

Université catholique de Louvain, Belgium

Linezolid toxicity in clinical practice: Towards a better detection of at-risk patients? Interim analysis of a prospective multicentric study

Maria Sanz-Codina

Medical University of Vienna, Austria

Plasma and soft tissue pharmacokinetics of cefiderocol in healthy volunteers


Many congratulations to the winners of the Young Investigator session:

Oral presentation: Mr. Aneeq Farooq (University of Hamburg, Germany)


Rapid fire talk: Dr. Gert-Jan Wijnant (UCLouvain, Belgium)



We were delighted to see many of you in Copenhagen and we look forward to seeing you again in Barcelona next year!